Skip to content

Inventories at other companies

Neogen logo
NeogenNEOG
$178.2M-21.0%
Zoetis logo
ZoetisZTS
$2.55B+7.8%
Danaher logo
DanaherDHR
$2.61B+3.0%
Agilent Technologies logo
Agilent TechnologiesA
$1.09B+9.9%
Quest Diagnostics logo
Quest DiagnosticsDGX
$225M+19.0%
Abbott logo
AbbottABT
$6.99B+5.3%

Other financials

Income statement

See full
Revenue$1.1B+14.3%
Gross profit$722.7M+15.9%
Operating income$362.6M+14.5%
Net income$278.4M+14.7%
EPS (diluted)$3.47+17.2%

Balance sheet

See full
Cash & equivalents$200.5M+22.3%
Total debt$575.5M-22.2%
Total equity$1.6B+7.5%
Total assets$3.4B+5.3%

Cash flow

See full
Operating cash flow$266.2M+11.9%
CapEx$32.0M+6.5%
Free cash flow$234.3M+12.7%

Valuation

See full
Market cap$41.53B+3.7%
Enterprise value$41.9B+3.3%
P/E37.9×-2.7×
P/S9.3×-0.6×

Profitability

See full
Gross margin62.1%+0.8pp
Operating margin31.6%+2.5pp
Net margin24.6%+1.9pp
FCF margin24.4%+2.8pp

Returns & leverage

See full
Return on equity72.9%+13.6pp
Debt / equity0.4×-0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Idexx Laboratories in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Idexx Laboratories's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Idexx Laboratories's inventories?
Idexx Laboratories (IDXX) reported inventories of $382.4M in Q1 2026.
How has Idexx Laboratories's inventories changed year-over-year?
Idexx Laboratories's inventories decreased by 3.4% year-over-year, from $395.99M to $382.4M.
What is the long-term trend for Idexx Laboratories's inventories?
Over 5 years (2020 to 2025), Idexx Laboratories's inventories has grown at a 12.5% compound annual growth rate (CAGR), from $209.87M to $377.76M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.